HIV infection and cardiovascular disease have both shared and distinct monocyte gene expression features: Women's

Juan Lin1, Erik Ehinger2, David B Hanna1

  • 1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, United States of America.

Plos One
|May 19, 2023
PubMed

Insights

Persistent inflammation in HIV patients drives cardiovascular disease (CVD). Non-classical monocytes (NCM) and intermediate monocytes (IM) show altered gene expression, particularly with comorbid HIV and CVD, highlighting potential therapeutic targets.

Area of Science:

  • Immunology
  • Cardiovascular Disease Research
  • HIV/AIDS Research

Background:

  • Persistent inflammation is a key factor in developing cardiovascular disease (CVD) as an HIV-associated comorbidity.
  • Innate immune cells, particularly monocytes, are significant drivers of inflammation in individuals with HIV.
  • Understanding monocyte subsets' roles is crucial for managing HIV-associated CVD.

Purpose of the Study:

  • To investigate the contribution of circulating non-classical monocytes (NCM) and intermediate monocytes (IM) to the host response in long-term HIV infection.
  • To examine the role of these monocyte subsets in HIV-associated CVD.
  • To analyze transcriptomic differences in monocytes based on HIV status and CVD presence.

Main Methods:

  • Study included women with and without chronic HIV infection, with and without subclinical CVD (C), matched for key demographics.
  • Transcriptomic features were assessed in isolated IM and NCM from peripheral blood mononuclear cells.
  • Gene expression patterns were compared across four groups: H-C-, H+C-, H-C+, and H+C+.

Main Results:

  • IM gene expression was minimally affected by HIV or CVD alone but showed a distinct signature with comorbid HIV/CVD, reversible with lipid-lowering treatment.
  • NCM exhibited altered gene expression in women with HIV, regardless of CVD status.
  • The most significant gene expression changes were observed in NCM from women with both HIV and CVD, with upregulated genes like LAG3 (CD223) identified as potential drug targets.

Conclusions:

  • Circulating monocytes in well-controlled HIV infection display extensive gene expression signatures, potentially indicating their role as viral reservoirs.
  • Gene expression alterations in HIV-positive individuals are amplified by the presence of subclinical CVD.
  • These findings underscore the complex interplay between HIV, monocytes, and cardiovascular health, suggesting avenues for targeted therapies.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
57
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
17
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
206
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
34